Liminatus Pharma Inc. (LIMN) vs Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Liminatus Pharma Inc. and Reviva Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Liminatus Pharma Inc. is the larger, with a market value of $5.6M against $5.0M — 1.1× the size. Across the 9 metrics below, Reviva Pharmaceuticals Holdings, Inc. leads on 6 and Liminatus Pharma Inc. on 3.

Valuation

Metric LIMN RVPH Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 13.53 0.42 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.84 0.74
EV/Sales n/m n/m 10.73
Earnings yield (559.52%) (252.17%) (28.84%)
Free cash flow yield (97.71%) (272.92%) (23.03%)

Profitability

Metric LIMN RVPH Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 294.43% (176.60%) (57.72%)
Return on assets (471.47%) (79.46%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LIMN RVPH Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (112.19%) 69.56% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LIMN RVPH Biotechnology median
Debt to equity 4.80 0.00 0.00
Current ratio 1.12 3.56 4.73
Net debt to EBITDA (0.37) 0.71 0.96

Dividend

Metric LIMN RVPH Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric LIMN RVPH Biotechnology median
Market cap 5.61m 5.00m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack